Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials

1. Ferrarotto, R.
2. Anderson, I.
3. Medgyasszay, B.
4. García-Campelo, M.R.
5. Edenfield, W.
6. Feinstein, T.M.
7. Johnson, J.M.
8. Kalmadi, S.
9. Lammers, P.E.
10. Sanchez-Hernandez, A.
11. Pritchett, Y.
12. Morris, S.R.
13. Malik, R.K.
14. Csőszi, T.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1002/CAM4.4089 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus